返回 Agendas
Direct-to-Patient Strategies That Are Changing the Landscape of Clinical Trials
Session Chair(s)
Leslie Chaney, PhD
VP, Patient Centric Services
Marken, United States
Home-based options in clinical trial design may allow patients to participate in trials from home. Home delivery of clinical trial materials and retrieval of biological samples may increase the number of patients who can enroll in clinical trials.
**Due to workshop format, seating will be limited and will be available on a first come, first served basis.
The Walter E. Washington Convention Center has stringent regulations on maximum room capacities, and they are strictly enforced. Once all seats are occupied, DIA will be required to close the workshop, and no more participants will be admitted. Interested attendees are encouraged to arrive at workshops early in order to ensure seating. Please note, as a workshop with interactivity, this offering will not be recorded.
Learning Objective : Identify the primary market drivers that support direct-to-patient (DTP) solutions; Articulate the challenges of traditional distribution practices; Provide three situations when a DTP solution should be considered; Identify DTP challenges and solutions to avoiding pitfalls; Explain what questions to ask to ensure regulatory considerations.
Speaker(s)
Facilitator
Gail Adinamis
GlobalCare Clinical Trials, LLC, United States
CEO
Facilitator
Michael Macneir
Marken, United States
VP Commercial Operations Americas